SUMMARY
INTRODUCTION
Syringomas are intradermal eccrin sweat gland tumors that cause dermal bulges. While it is mostly seen in adolescence, its prevalence at women is two-fold more than men. Also, progressive lesions may be encountered at latter ages (1) . Clinically, syringomas are small (1-3 mm of diameter), multiple, rigid lesions and they have the same color with skin or may be more yellowish.
They are commonly located around at lower eyelids and nose but may be present at axillary region, neck, chest, upper arm and abdomen. The lesions are mostly bilateral and symmetrical (2) (3) (4) .
Vulvar syringomas are encountered extremely rare;
hence there are few case reports in the literature. In this article, a vulvar syringoma case which had a confirmed diagnosis histopathologically is presented and the literature is reviewed. 
DISCUSSION
Syringomas were firstly described as tuberosum lymphangioma multiplex by Kaposi and Biesiadeki in 1872 (5, 6) . Since that date, the structure of intraepidermal eccrin sweat glands at this disorder has been examined by monoclonal antikeratin antibody tests, electron microscope and histochemistry studies (7) .
These tumors are commonly seen at adolescent women Vulvar syringoma and they are mostly placed at face, under the eyes and malar region. Syringomas are typically asymptomatic, irreversible cases and malignity is reported rarely (9) .
Although onset is commonly at puberty; as in our case, it may also be at further ages (8) .
Syringomas of genital region are rarely reported in the literature as sporadic cases. Similar to our case, intermittent pruritus complaining which increases during menstruation was reported in these publications (10) .
Syringomas may be present at approximately 20 % of patients with Down syndrome. This rate is 30-fold more than the rate in other diseases with mental retardation. Histopathological examination of syringomas seen in these cases revealed presence of calcinosis (11, 12) . Calcinosis was not detected histopathologically and Down syndrome was not present at our case.
Although families with familial syringoma history were reported in the literature, for now a hereditary transmission could not be demonstrated for this disease (7, 13) . Syringomas may be seen with Marfan syndrome and Ehler-Danlos syndrome (14) . Family history was clear for our patient.
It is thought that hormonal factors also have role in the development of syringomas. Syringomas are thought to be sensitive to estrogen. The diameters of the lesions were reported to increase with pregnancy, premenstrual period and oral contraceptive use (14) . By demonstrating presence of estrogen and progesterone receptors at patients with extragenital syringoma, Wallace et al. supported the idea that syringomas would be under hormonal control (1) .
In contrast, Huang et al. reported that they detected estrogen and progesterone receptors at none of the patients with vulvar syringoma (10) .
In the light of histochemistry and electronmicroscopic findings, syringoma is an adenoma of eccrin ducts.
Comma-shaped cystic ducts including amorphous substance surrounded with two lines of epithelium cells at dermis form typical histopathological image.
Cysts with keratin may be present near to epidermis.
These may sometimes be ruptured and cause foreign body reaction (15) .
Diagnosing vulvar syringomas is not challenging. But millia, verru plana, basal cell carcinoma, multiple nevoid basal cell carcinoma syndrome, eruptive vellus cyst, xanthomas, epidermal cysts, steocystoma multiplex, Fox-fordyce disease, condyloma accuminata, calcinosis cutis should be considered in differential diagnosis (10, 14) . Also, liken planus and secondary syphilis should be considered at differential diagnosis of eruptive syringoma.
Follow-up with observation may be offered for asymptomatic cases with syringoma while symptomatic cases can be treated with electrocauterization, laser, topical atropine sulphate, topical tretionin and isotretionin. The best treatment method of syringomas is complete destruction of the tumor and it may be done with surgical excision, electrodessication, chemical peeling, topical atropine or tretinoin, cryosurgery and laser surgery (14, 16) .
Topical steroids and antihistamines are not effective.
Topical atropine sulphate and tretinoin may be used successfully for treatment of pruritus (10) .
Although laser treatment is frequently preferred for treatment of skin tumors; it is reported in only a few cases with syringoma in the literature. In our case, laser vaporization was considered because it was more reliable as it was easy to perform, less painful, had less complication rate and better cosmetic outcomes.
In conclusion, syringomas should be kept in mind at differential diagnosis of cases present with complaining of vulvar pruritus at fertile period. Laser vaporization should be preferred at treatment of syringomas as it is safe and easy to perform. But prospective studies with more cases are needed to evaluate long-term recurrence and cosmetic outcomes.
